Rongkuan Frank Hu, Starna Therapeutics CEO
Starna Therapeutics emerges with financing for mRNA vaccine and therapies
Starna Therapeutics has emerged with 150 million Yuan, or about $24 million, in Series A financing to take on two difficult areas in biotech R …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
